Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof-of-concept, Multi-center, Randomized, Double-blind, Placebo-controlled, Two-way Crossover Study to Investigate the Effect Strength of BAY 2586116 on the Apnea-hypopnea-index After Repetitive Nasal Doses Compared to Placebo in 80 Valid Participants With Moderate to Severe Obstructive Sleep Apnea

NCT04713826 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04713826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04713826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof-of-concept, Multi-center, Randomized, Double-blind, Placebo-controlled, Two-way Crossover Study to Investigate the Effect Strength of BAY 2586116 on the Apnea-hypopnea-index After Repetitive Nasal Doses Compared to Placebo in 80 Valid Participants With Moderate to Severe Obstructive Sleep Apnea
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
March 3, 2021
Completion date
November 11, 2021
Enrollment
93 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sleep apnea, obstructive